CN104250650A - Delta-6 fatty acid dehydrogenase gene and application thereof - Google Patents
Delta-6 fatty acid dehydrogenase gene and application thereof Download PDFInfo
- Publication number
- CN104250650A CN104250650A CN201410360120.2A CN201410360120A CN104250650A CN 104250650 A CN104250650 A CN 104250650A CN 201410360120 A CN201410360120 A CN 201410360120A CN 104250650 A CN104250650 A CN 104250650A
- Authority
- CN
- China
- Prior art keywords
- fatty acid
- acid dehydrogenase
- leu
- ile
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000194 fatty acid Substances 0.000 title claims abstract description 53
- 101710088194 Dehydrogenase Proteins 0.000 title claims abstract description 50
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract description 7
- 229930195729 fatty acid Natural products 0.000 title abstract description 7
- 150000004665 fatty acids Chemical class 0.000 title abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 22
- 239000002773 nucleotide Substances 0.000 claims abstract description 21
- 241000306282 Umbelopsis isabellina Species 0.000 claims abstract description 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 14
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 12
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 12
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 12
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 12
- 229960002733 gamolenic acid Drugs 0.000 abstract description 12
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 5
- 238000010276 construction Methods 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 239000013598 vector Substances 0.000 abstract description 3
- 235000020778 linoleic acid Nutrition 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 29
- 238000000034 method Methods 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 18
- 239000013604 expression vector Substances 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 239000002299 complementary DNA Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 238000003259 recombinant expression Methods 0.000 description 6
- 230000003321 amplification Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000008827 biological function Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 208000032880 autosomal dominant 6 intellectual disability Diseases 0.000 description 2
- 201000000179 autosomal dominant non-syndromic intellectual disability 6 Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 108010054813 diprotin B Proteins 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NTUPOKHATNSWCY-PMPSAXMXSA-N (2s)-2-[[(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=CC=C1 NTUPOKHATNSWCY-PMPSAXMXSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- FDAZDMAFZYTHGS-XVYDVKMFSA-N Ala-His-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O FDAZDMAFZYTHGS-XVYDVKMFSA-N 0.000 description 1
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- BLTRAARCJYVJKV-QEJZJMRPSA-N Ala-Lys-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O BLTRAARCJYVJKV-QEJZJMRPSA-N 0.000 description 1
- MAZZQZWCCYJQGZ-GUBZILKMSA-N Ala-Pro-Arg Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MAZZQZWCCYJQGZ-GUBZILKMSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 1
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- 241001149952 Amylomyces rouxii Species 0.000 description 1
- BGDILZXXDJCKPF-CIUDSAMLSA-N Arg-Gln-Cys Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O BGDILZXXDJCKPF-CIUDSAMLSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 1
- ZPWMEWYQBWSGAO-ZJDVBMNYSA-N Arg-Thr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZPWMEWYQBWSGAO-ZJDVBMNYSA-N 0.000 description 1
- POZKLUIXMHIULG-FDARSICLSA-N Arg-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N POZKLUIXMHIULG-FDARSICLSA-N 0.000 description 1
- YHZQOSXDTFRZKU-WDSOQIARSA-N Arg-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N)=CNC2=C1 YHZQOSXDTFRZKU-WDSOQIARSA-N 0.000 description 1
- XMZZGVGKGXRIGJ-JYJNAYRXSA-N Arg-Tyr-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O XMZZGVGKGXRIGJ-JYJNAYRXSA-N 0.000 description 1
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 1
- AYZAWXAPBAYCHO-CIUDSAMLSA-N Asn-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N AYZAWXAPBAYCHO-CIUDSAMLSA-N 0.000 description 1
- UPALZCBCKAMGIY-PEFMBERDSA-N Asn-Gln-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UPALZCBCKAMGIY-PEFMBERDSA-N 0.000 description 1
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 1
- BKDDABUWNKGZCK-XHNCKOQMSA-N Asn-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O BKDDABUWNKGZCK-XHNCKOQMSA-N 0.000 description 1
- PBSQFBAJKPLRJY-BYULHYEWSA-N Asn-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N PBSQFBAJKPLRJY-BYULHYEWSA-N 0.000 description 1
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
- MYCSPQIARXTUTP-SRVKXCTJSA-N Asn-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N MYCSPQIARXTUTP-SRVKXCTJSA-N 0.000 description 1
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 1
- XZFONYMRYTVLPL-NHCYSSNCSA-N Asn-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N XZFONYMRYTVLPL-NHCYSSNCSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- KVPHTGVUMJGMCX-BIIVOSGPSA-N Asp-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N)C(=O)O KVPHTGVUMJGMCX-BIIVOSGPSA-N 0.000 description 1
- WSXDIZFNQYTUJB-SRVKXCTJSA-N Asp-His-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O WSXDIZFNQYTUJB-SRVKXCTJSA-N 0.000 description 1
- LTCKTLYKRMCFOC-KKUMJFAQSA-N Asp-Phe-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LTCKTLYKRMCFOC-KKUMJFAQSA-N 0.000 description 1
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 1
- CXEFNHOVIIDHFU-IHPCNDPISA-N Asp-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(=O)O)N CXEFNHOVIIDHFU-IHPCNDPISA-N 0.000 description 1
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 101100008162 Candida tropicalis Cytb5 gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000007605 Cytochromes b5 Human genes 0.000 description 1
- 108010007167 Cytochromes b5 Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- REJJNXODKSHOKA-ACZMJKKPSA-N Gln-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N REJJNXODKSHOKA-ACZMJKKPSA-N 0.000 description 1
- JSYULGSPLTZDHM-NRPADANISA-N Gln-Ala-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O JSYULGSPLTZDHM-NRPADANISA-N 0.000 description 1
- NNXIQPMZGZUFJJ-AVGNSLFASA-N Gln-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N NNXIQPMZGZUFJJ-AVGNSLFASA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 1
- MXPBQDFWIMBACQ-ACZMJKKPSA-N Glu-Cys-Cys Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(O)=O MXPBQDFWIMBACQ-ACZMJKKPSA-N 0.000 description 1
- LVCHEMOPBORRLB-DCAQKATOSA-N Glu-Gln-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O LVCHEMOPBORRLB-DCAQKATOSA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- LUJVWKKYHSLULQ-ZKWXMUAHSA-N Gly-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN LUJVWKKYHSLULQ-ZKWXMUAHSA-N 0.000 description 1
- YSDLIYZLOTZZNP-UWVGGRQHSA-N Gly-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN YSDLIYZLOTZZNP-UWVGGRQHSA-N 0.000 description 1
- OMOZPGCHVWOXHN-BQBZGAKWSA-N Gly-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN OMOZPGCHVWOXHN-BQBZGAKWSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- TTZAWSKKNCEINZ-AVGNSLFASA-N His-Arg-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O TTZAWSKKNCEINZ-AVGNSLFASA-N 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- WOAMZMXCLBBQKW-KKUMJFAQSA-N His-Cys-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC2=CN=CN2)N)O WOAMZMXCLBBQKW-KKUMJFAQSA-N 0.000 description 1
- VHHYJBSXXMPQGZ-AVGNSLFASA-N His-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N VHHYJBSXXMPQGZ-AVGNSLFASA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 1
- WJGSTIMGSIWHJX-HVTMNAMFSA-N His-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N WJGSTIMGSIWHJX-HVTMNAMFSA-N 0.000 description 1
- IWXMHXYOACDSIA-PYJNHQTQSA-N His-Ile-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O IWXMHXYOACDSIA-PYJNHQTQSA-N 0.000 description 1
- YYOCMTFVGKDNQP-IHRRRGAJSA-N His-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N YYOCMTFVGKDNQP-IHRRRGAJSA-N 0.000 description 1
- YIGCZZKZFMNSIU-RWMBFGLXSA-N His-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N YIGCZZKZFMNSIU-RWMBFGLXSA-N 0.000 description 1
- WSWAUVHXQREQQG-JYJNAYRXSA-N His-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O WSWAUVHXQREQQG-JYJNAYRXSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 1
- DMHGKBGOUAJRHU-UHFFFAOYSA-N Ile-Arg-Pro Natural products CCC(C)C(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O DMHGKBGOUAJRHU-UHFFFAOYSA-N 0.000 description 1
- ZGGWRNBSBOHIGH-HVTMNAMFSA-N Ile-Gln-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZGGWRNBSBOHIGH-HVTMNAMFSA-N 0.000 description 1
- JRYQSFOFUFXPTB-RWRJDSDZSA-N Ile-Gln-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N JRYQSFOFUFXPTB-RWRJDSDZSA-N 0.000 description 1
- MQFGXJNSUJTXDT-QSFUFRPTSA-N Ile-Gly-Ile Chemical compound N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)O MQFGXJNSUJTXDT-QSFUFRPTSA-N 0.000 description 1
- HQEPKOFULQTSFV-JURCDPSOSA-N Ile-Phe-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)O)N HQEPKOFULQTSFV-JURCDPSOSA-N 0.000 description 1
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 1
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 1
- NAFIFZNBSPWYOO-RWRJDSDZSA-N Ile-Thr-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N NAFIFZNBSPWYOO-RWRJDSDZSA-N 0.000 description 1
- KBDIBHQICWDGDL-PPCPHDFISA-N Ile-Thr-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N KBDIBHQICWDGDL-PPCPHDFISA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 1
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- IWMJFLJQHIDZQW-KKUMJFAQSA-N Leu-Ser-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IWMJFLJQHIDZQW-KKUMJFAQSA-N 0.000 description 1
- YIRIDPUGZKHMHT-ACRUOGEOSA-N Leu-Tyr-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YIRIDPUGZKHMHT-ACRUOGEOSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- XTONYTDATVADQH-CIUDSAMLSA-N Lys-Cys-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O XTONYTDATVADQH-CIUDSAMLSA-N 0.000 description 1
- RZHLIPMZXOEJTL-AVGNSLFASA-N Lys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N RZHLIPMZXOEJTL-AVGNSLFASA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- QZONCCHVHCOBSK-YUMQZZPRSA-N Lys-Gly-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O QZONCCHVHCOBSK-YUMQZZPRSA-N 0.000 description 1
- SQJSXOQXJYAVRV-SRVKXCTJSA-N Lys-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N SQJSXOQXJYAVRV-SRVKXCTJSA-N 0.000 description 1
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 1
- DNWBUCHHMRQWCZ-GUBZILKMSA-N Lys-Ser-Gln Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O DNWBUCHHMRQWCZ-GUBZILKMSA-N 0.000 description 1
- LKDXINHHSWFFJC-SRVKXCTJSA-N Lys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N LKDXINHHSWFFJC-SRVKXCTJSA-N 0.000 description 1
- UWHCKWNPWKTMBM-WDCWCFNPSA-N Lys-Thr-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O UWHCKWNPWKTMBM-WDCWCFNPSA-N 0.000 description 1
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 1
- ULLIQRYQNMAAHC-RWMBFGLXSA-N Met-His-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N ULLIQRYQNMAAHC-RWMBFGLXSA-N 0.000 description 1
- HSJIGJRZYUADSS-IHRRRGAJSA-N Met-Lys-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HSJIGJRZYUADSS-IHRRRGAJSA-N 0.000 description 1
- MQASRXPTQJJNFM-JYJNAYRXSA-N Met-Pro-Phe Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MQASRXPTQJJNFM-JYJNAYRXSA-N 0.000 description 1
- XIGAHPDZLAYQOS-SRVKXCTJSA-N Met-Pro-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 XIGAHPDZLAYQOS-SRVKXCTJSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 1
- DFEVBOYEUQJGER-JURCDPSOSA-N Phe-Ala-Ile Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O DFEVBOYEUQJGER-JURCDPSOSA-N 0.000 description 1
- FGXIJNMDRCZVDE-KKUMJFAQSA-N Phe-Cys-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N FGXIJNMDRCZVDE-KKUMJFAQSA-N 0.000 description 1
- VZFPYFRVHMSSNA-JURCDPSOSA-N Phe-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 VZFPYFRVHMSSNA-JURCDPSOSA-N 0.000 description 1
- VDTYRPWRWRCROL-UFYCRDLUSA-N Phe-Val-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VDTYRPWRWRCROL-UFYCRDLUSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- FCCBQBZXIAZNIG-LSJOCFKGSA-N Pro-Ala-His Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O FCCBQBZXIAZNIG-LSJOCFKGSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 1
- HOTVCUAVDQHUDB-UFYCRDLUSA-N Pro-Phe-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 HOTVCUAVDQHUDB-UFYCRDLUSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- CNIIKZQXBBQHCX-FXQIFTODSA-N Ser-Asp-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O CNIIKZQXBBQHCX-FXQIFTODSA-N 0.000 description 1
- MOQDPPUMFSMYOM-KKUMJFAQSA-N Ser-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N MOQDPPUMFSMYOM-KKUMJFAQSA-N 0.000 description 1
- YIUWWXVTYLANCJ-NAKRPEOUSA-N Ser-Ile-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YIUWWXVTYLANCJ-NAKRPEOUSA-N 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- HBTCFCHYALPXME-HTFCKZLJSA-N Ser-Ile-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HBTCFCHYALPXME-HTFCKZLJSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- OSFZCEQJLWCIBG-BZSNNMDCSA-N Ser-Tyr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSFZCEQJLWCIBG-BZSNNMDCSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 1
- YLXAMFZYJTZXFH-OLHMAJIHSA-N Thr-Asn-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O YLXAMFZYJTZXFH-OLHMAJIHSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- ABWNZPOIUJMNKT-IXOXFDKPSA-N Thr-Phe-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O ABWNZPOIUJMNKT-IXOXFDKPSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- QYDKSNXSBXZPFK-ZJDVBMNYSA-N Thr-Thr-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYDKSNXSBXZPFK-ZJDVBMNYSA-N 0.000 description 1
- NDLHSJWPCXKOGG-VLCNGCBASA-N Thr-Trp-Tyr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N)O NDLHSJWPCXKOGG-VLCNGCBASA-N 0.000 description 1
- CYCGARJWIQWPQM-YJRXYDGGSA-N Thr-Tyr-Ser Chemical compound C[C@@H](O)[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CO)C([O-])=O)CC1=CC=C(O)C=C1 CYCGARJWIQWPQM-YJRXYDGGSA-N 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- XXJDYWYVZBHELV-TUSQITKMSA-N Trp-Trp-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CCCCN)C(=O)O)N XXJDYWYVZBHELV-TUSQITKMSA-N 0.000 description 1
- OEVJGIHPQOXYFE-SRVKXCTJSA-N Tyr-Asn-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OEVJGIHPQOXYFE-SRVKXCTJSA-N 0.000 description 1
- DANHCMVVXDXOHN-SRVKXCTJSA-N Tyr-Asp-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DANHCMVVXDXOHN-SRVKXCTJSA-N 0.000 description 1
- WZQZUVWEPMGIMM-JYJNAYRXSA-N Tyr-Gln-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O WZQZUVWEPMGIMM-JYJNAYRXSA-N 0.000 description 1
- JKUZFODWJGEQAP-KBPBESRZSA-N Tyr-Gly-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O JKUZFODWJGEQAP-KBPBESRZSA-N 0.000 description 1
- WPXKRJVHBXYLDT-JUKXBJQTSA-N Tyr-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N WPXKRJVHBXYLDT-JUKXBJQTSA-N 0.000 description 1
- CNNVVEPJTFOGHI-ACRUOGEOSA-N Tyr-Lys-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CNNVVEPJTFOGHI-ACRUOGEOSA-N 0.000 description 1
- LVILBTSHPTWDGE-PMVMPFDFSA-N Tyr-Trp-Lys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=C(O)C=C1 LVILBTSHPTWDGE-PMVMPFDFSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- HZWPGKAKGYJWCI-ULQDDVLXSA-N Tyr-Val-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O HZWPGKAKGYJWCI-ULQDDVLXSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- ZLFHAAGHGQBQQN-AEJSXWLSSA-N Val-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZLFHAAGHGQBQQN-AEJSXWLSSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- JIODCDXKCJRMEH-NHCYSSNCSA-N Val-Arg-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N JIODCDXKCJRMEH-NHCYSSNCSA-N 0.000 description 1
- HNWQUBBOBKSFQV-AVGNSLFASA-N Val-Arg-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HNWQUBBOBKSFQV-AVGNSLFASA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- WNZSAUMKZQXHNC-UKJIMTQDSA-N Val-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N WNZSAUMKZQXHNC-UKJIMTQDSA-N 0.000 description 1
- WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
- UOUIMEGEPSBZIV-ULQDDVLXSA-N Val-Lys-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UOUIMEGEPSBZIV-ULQDDVLXSA-N 0.000 description 1
- BCBFMJYTNKDALA-UFYCRDLUSA-N Val-Phe-Phe Chemical compound N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O BCBFMJYTNKDALA-UFYCRDLUSA-N 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010089198 phenylalanyl-prolyl-arginine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a nucleotide sequence isolated from Mortierella isabellina M6-22 and encoding delta-6 fatty acid dehydrogenase, the nucleotide sequence is shown as SEQIDNO:1, and the amino acid sequence encoding by the gene is shown as SEQIDNO:2. Through the construction of recombinant vector and expression in Saccharomyces cerevisiae, the expression product has the functions of delta 6-fatty acid dehydrogenase, and can catalyze the linoleic acid to convert into gamma-linolenic acid.
Description
Technical field
The invention belongs to biological technical field and field of genetic engineering, relate to from a kind of filamentous fungus---the Mortierella isabellina of Mucor (
mortierella isabellina) Δ of cloning in M6-22
6-fatty acid dehydrogenase gene, and this gene is directly connected with different carriers, proceed in bacterium, yeast, plant or animal, utilize its coded delta
6-fatty acid dehydrogenase produces and comprises the polyunsaturated fatty acids such as gamma-linolenic acid.
Background technology
Gamma-linolenic acid (γ-linolenic acid) is a kind of Multifunctional grease composition, it is the polyunsaturated fatty acid of needed by human, there is multiple important physiological activity, the physiological regulating control and substance metabolism of body play an important role, as reducing blood-fat, antithrombotic cardiovascular and cerebrovascular, prevention and therapy hypertension, atherosclerosis, strengthen the immunologic function of human body, also have antitumor, anti peroxidation of lipid, suppress the effect [Dong Jieming etc. of ulcer and the enhancing aspect such as Regular Insulin and fat-reducing, 2003, health research, 32 (3): 299-301].Especially the medical value in diabetes, cardiovascular disorder and cancer, gamma-linolenic acid has become the focus of academia's research.
Δ
6-fatty acid dehydrogenase energy specific catalytic linolic acid (linoleic acid, C18:2 Δ
9,12) and alpha-linolenic acid (α-linolenic acid, C18:3 Δ
9,12,15) carboxyl terminal the 6th and the 7th carbon atom between insert a new double bond, dehydrogenation forms gamma-linolenic acid (γ-linolenic acid, C18:3 Δ respectively
6,9,12) and therapic acid (stearidonic acid, C18:4 Δ
6,9,12,15), they form the polyunsaturated fatty acid (long-chain polyunsaturated fatty acid, LC-PUFAs) of other long-chain more further by carbochain extension and dehydrogenation, therefore Δ
6-fatty acid dehydrogenase is the key enzyme of synthesis of long-chain polyunsaturated fatty acids in people and mammalian body.These long chain polyunsaturated fatty acidss are body tissue microbial film moietys, play effect [the Napier JA et al maintaining cell normal function and increase body resistance, 1999, Curr.Opin.Plant Biol, 2:123-127], be also precursor [Horrobinn DF, 1992 that prostaglandin(PG), prostacyclin and leukotrienes etc. have the self-regulation thing of strong physiologically active simultaneously, Prog Lipid Res., 31:163-194].Δ
6the reduction of-fatty acid enzymic activity reduces causing the resultant quantity of gamma-linolenic acid, causes the various disorders of human body, and then causes various disease.Therefore, from different organism, Δ is cloned
6-fatty acid dehydrogenase gene, then proceed to different host cells after connecting from different expression vector and express, utilizes host to produce gamma-linolenic acid and other long chain polyunsaturated fatty acidss have very big application prospect.
Because people more and more recognize the importance of gamma-linolenic acid and other long chain polyunsaturated fatty acidss, therefore attention is turned to again Δ
6in the research of-fatty acid dehydrogenase.Δ
6-fatty acid dehydrogenase belongs to a class film intergrase, the difficulty due to separation andpreconcentration embrane-associated protein very large [MaKeon, 1981, Enzymology method, 12141-12147; Wang etc., 1988, plant physiology biological chemistry, 26:777-792], therefore conventional biochemical method is difficult to obtain comprising Δ
6-fatty acid dehydrogenase, and can only by carrying out preliminary study at interior various embrane-associated protein character desaturase superior bodies to the nucleotide sequence of enzyme, for Δ
6the biological function verification of-fatty acid dehydrogenase, many laboratories have employed clones relevant gene and proceeds in various recipient cell from various organism, in recipient cell, then observe the method that its lipid acid changes.The result of alignment shows, coded delta
6the nucleotide sequence of-fatty acid dehydrogenase has common mechanism characteristics: there are three Histidine conserved regions, forms the structure [Kyte et al, 1982, J.Mol.Biol.157:105-132] of tetratransmembrane, in addition, except cyanobacteria, and Eukaryotic Δ
6the aminoterminal of-fatty acid dehydrogenase is all containing being similar to cytochrome b5 (Cytb5) haem bonding pad (HPGG) [Napier JA, Sayanova O, Stobart AK, et al., 1997, Biochem.J., 157:105-132], these are all that maintenance dehydrogenase activity is necessary.
At present, from the different sourcess such as animal, plant, microorganism, many Δs are separated to by different kinds of molecules biological method
6the homologous sequence of-fatty acid dehydrogenase gene, and prove that there is corresponding biological function, but, although obtain a lot of Δ
6the gene order of-fatty acid dehydrogenase, but the technical difficulty existed in the purifying of enzyme, still not do not disclose its biochemical characteristic physical environment from enzyme level at present.Therefore, can only by means of the Δ excavating more different sources
6-fatty acid dehydrogenase gene sequence, carrys out more deep announcement Δ by gene sequencing
6the biological function of-fatty acid dehydrogenase, and for the in the future purifying of enzyme and the announcement of biochemical characteristic and further application lay the first stone.In addition, the dehydrogenase gene catalytic activity that these different sourcess are separated to is lower and great majority do not have strict specificity to fatty acid substrate chain length, double bond number and position of double bond, except target product, also can produce some non-specific lipid acid.Therefore, need to continue the Δ that screening has high substrate specificity
6-fatty acid dehydrogenase gene, and using gene engineering technique builds the transgenic rape tannin plant that specificity produces polyunsaturated fatty acid, directly improves oil quality, more has actual application value.This research excavates efficient, the specific gene of polyunsaturated fatty acid synthesis, for the quality-improving of transgenosis fatty acid product of new generation lays the foundation by multiple means.
Summary of the invention
An object of the present invention is to provide a kind of from Mortierella isabellina (
mortierella isabellina) be separated the Δ obtained in M6-22
6the amino acid of-fatty acid dehydrogenase gene and this genes encoding, the fragment of this gene nucleotide series or nucleotide sequence is as shown in SEQ ID NO:1, or with the nucleotide sequence of SEQ ID NO:1 complementation, this gene order is long is 1515bp(base), wherein 1-1515 is coded delta
6the open reading frame of-fatty acid dehydrogenase mature polypeptide; Polypeptide as shown in SEQ ID NO:2 of the aminoacid sequence of this genes encoding or its fragment.
Another object of the present invention is to provide a kind of containing Δ
6the recombinant expression vector of-fatty acid dehydrogenase gene, be gene shown in SEQ ID NO:1 is directly connected from different expression vector (plasmid, virus or vehicle) constructed by recombinant vectors.
The Δ deriving from Mortierella isabellina M6-22 containing coding can be built by method well-known to those having ordinary skill in the art
6the expression vector of the nucleotide sequence of-fatty acid dehydrogenase and suitable to transcribe/translational control element.These methods comprise [Sambroook, et al, the Molecular Cloning such as recombinant DNA technology in vi, DNA synthetic technology, In vivo recombination technology, a Laboratory Manual, Cold Spring Harbor Laboratory, New York, 1989].Described coding Mortierella isabellina M6-22 Δ
6the nucleotide sequence of-fatty acid dehydrogenase can be effectively connected in the appropriate promotor of expression vector, synthesizes to instruct mRNA.The representative example of these promotors has: colibacillary lac or trp promotor; The PL promotor of lambda particles phage; Eukaryotic promoter comprise CMV early promoter, HSV thymidine kinase promoter, early stage and late period SV40 promotor, the LTRs of retrovirus and some other known can the promotor expressed in prokaryotic cell prokaryocyte or eukaryotic cell or its virus of controlling gene.Expression vector also comprises the ribosome bind site and transcription terminator etc. of translation initiation.Inserting enhancer sequence in the carrier will make its transcribing in higher eucaryotic cells be enhanced.Enhanser is the cis-acting factors that DNA expresses, and usual nearly 10-300bp, acts on promotor transcribing with enhancing gene, as adenovirus cancers.
Another object of the present invention is to provide a kind of containing Δ
6the host cell of-fatty acid dehydrogenase gene or above-mentioned recombinant expression vector, this cell is bacterial cell, fungal cell, vegetable cell or zooblast, or the offspring of these host cells, and the representative example of host cell has: intestinal bacteria; Fungal cell or yeast; Vegetable cell is as rape, tobacco, soybean; Insect cell is as fruit bat S2 or Sf9; Zooblast is as CHO, COS or Bowes melanoma cells etc.
Optimize host cell with nucleotide sequence of the present invention or the recombinant vectors containing nucleotide sequence to be undertaken by method well-known to those having ordinary skill in the art.When host be prokaryotic organism as intestinal bacteria time, the competent cell that can absorb DNA can collect thalline in exponential phase of growth, uses CaCl
2, the method such as electroporation carries out.When host is eukaryote, DNA infection protocol can be selected.The methods such as microinjection, electroporation, liposome packaging.
Nucleotide sequence of the present invention is DNA form, DNA form comprises the DNA of cDNA, genomic dna or synthetic, DNA can be strand or double-strand, and the coding region sequence of encoding mature polypeptide can or the varient of degeneracy identical with the coding region sequence shown in SEQ ID NO:2.
The present invention also comprises the Δ of encoding and obtaining from Mortierella isabellina M6-22
6the fragment of the nucleotide sequence of-fatty acid dehydrogenase.As used in the present invention, term " fragment " refers to the nucleotide sequence of the polypeptide of identical biological function or the activity can encoded and substantially keep the present invention natural.By elaboration herein, such fragment, to be considered within the ken of those skilled in the art.
Polypeptide in the present invention and nucleotide sequence preferably provide with the form be separated, and are more preferably purified to homogeneous.
In the present invention, specific nucleotide sequence can obtain by multiple method.Such as, with hybridization technique isolated nucleic acid sequence well known in the art.These technology including, but not limited to: (1) hybridizes the nucleotide sequence to detect homology with probe and genome or cDNA library; (2) resistance screening of expression library is to detect the nucleotide sequence fragment of the clone with structural features.
Sequence dna fragment of the present invention also can obtain by following method: (1) is separated double chain DNA sequence from genomic dna; (2) chemical synthesising DNA sequence is to obtain the double-stranded DNA of described polypeptide.
In the above-mentioned method mentioned, isolation of genomic DNA is least conventional.The direct chemical synthesis of DNA sequence dna is the method often selected.The method more often selected is the separation of DNA sequence dna.The standard method being separated interested cDNA is donorcells separating mRNA from this gene of high expression level and transcribes, and forms plasmid or phage cDNA library.The method extracting mRNA has multiple proven technique, also can obtain from commercial channels with test kit.And construction cDNA library is also usual method.When in conjunction with polymerase chain reaction technology (PCR), even if few expression product also can be cloned.
Nucleotide sequence provided by the invention is a kind of efficient specific fatty acid dehydrogenase, be converted in microorganism cells body after it can being connected with carrier and produce unsaturated fatty acids, have product specificities high, with short production cycle, produce by place, weather, the impact in season and utilize different bacterial classifications and substratum to be applicable to the advantages such as development function grease, may be used for commercially producing, directly improve oil quality, more there is actual application value.Using gene engineering technique of the present invention builds the transgenic yeast cell production unsaturated fatty acids that specificity produces polyunsaturated fatty acid, have simple to operate, cost is low, feasibility advantages of higher, for the quality-improving of transgenosis fatty acid product of new generation lays the foundation.
Accompanying drawing explanation
Fig. 1 is the Δ of Mortierella isabellina M6-22 of the present invention
6-fatty acid dehydrogenase and Zygosaccharomyces rouxii Δ
6the amino acid sequence homology comparison diagram of-fatty acid dehydrogenase; Wherein MID6-1 is Mortierella isabellina M6-22 Δ of the present invention
6-fatty acid dehydrogenase, MRD6 is Zygosaccharomyces rouxii Δ
6-fatty acid dehydrogenase, Consensus is aminoacid sequence identical between two sequences;
The saccharomyces cerevisiae expression pY3MID6-1 of Fig. 2 constructed by the present invention;
Fig. 3 is the gas chromatogram that the present invention contains the transgenic yeast of pYES3/CT empty carrier;
Fig. 4 is the gas chromatogram that the present invention contains the transgenic yeast of recombinant plasmid pY3MID6-1.
Embodiment
Below in conjunction with drawings and Examples, the present invention is described in further detail, but scope is not limited to described content, the reagent used in embodiment and method, if no special instructions, all adopts conventional reagent and use ordinary method.
Embodiment 1: be separated Δ from Mortierella isabellina M6-22
6the nucleotide sequence of-fatty acid dehydrogenase
According to the RNAseq analytical results of Mortierella isabellina M6-22, find a coded delta
6the mRNA sequence of-fatty acid dehydrogenase, analyzes the encoding sequence of acquisition one section coding whole protein further, and according to encoding sequence design and synthesis Auele Specific Primer (primer 1 and primer 2).Mortierella isabellina M6-22 is inoculated in PDA liquid nutrient medium simultaneously, cultivate 48h for 28 DEG C, collect mycelium, hypha powder is become by liquid nitrogen grinding, then adopt eukaryotic cell total RNA extraction reagent box (Promega Products) to extract the total serum IgE of Mortierella isabellina M6-22, recycling Reverse Transcription box (fermentas Products) reverse transcription synthesis Article 1 cDNA, with this cDNA for template, carry out PCR reaction with primer 1 and primer 2, react component used and amplification condition as follows:
Primer 1:MID6-1F1:5`-ATGCCTCCTAACAATAGGGCTATCGA-3`
Primer 2: MID6-1R1:5`-TCACGCATGAGGTGCTACCATCTCT-3`;
PCR amplification system (25 μ L) is composed as follows:
10×Ex Taq Buffer 2.5 μL
dNTP(2.5 μmol/L) 2 μL
Template 3 μ L
MID6-1F1(10 μmol/L) 2 μL
MID6-1R1(10 μmol/L) 2 μL
Ex Taq DNA polymerase(5U/μL) 2 μL
Aseptic ddH
2o complements to 25 μ L
Amplification condition: 94 DEG C of sex change 4min, then carry out 30 circulations with 94 DEG C of 1min, 58 DEG C of 1min, 72 DEG C of 2min, amplified production is connected in pMD18-T carrier according to method in partial sequence amplification, sends order-checking after checking is correct.Result display the clip size obtained that increases be 1515bp, by the aminoacid sequence of its coding in Genebank database with Blast(Basic Local Alignment Search Tool) program carries out Homology search, result for retrieval shows that the homologous fragment the most similar to this fragment is Δ
6-fatty acid dehydrogenase, but and incomplete same, prove that the fragment increased is the Partial Fragment of new potential dehydrogenase gene.
Embodiment 2: the homology search of institute's isolated nucleic acid sequence
By the Δ inferred
6the aminoacid sequence of-fatty acid dehydrogenase carries out homology search on Genbank, and gained homologous sequence major part is the sequence of coded delta 6-fatty acid dehydrogenase, and minority is the sequence of putative protein, selects the Δ having done functional verification
6-fatty acid dehydrogenase does tetraploid rice, wherein with Zygosaccharomyces rouxii (
mucor rouxii) Δ
6-fatty acid dehydrogenase (AF290983_1) similarity is the highest, is 56%.(Fig. 1, MID6-1 are Mortierella isabellina M6-22 Δ of the present invention
6-fatty acid dehydrogenase, MRD6 is Zygosaccharomyces rouxii Δ
6-fatty acid dehydrogenase, Consensus is aminoacid sequence identical between two sequences, and this illustrates that the enzyme coded by nucleotide sequence provided by the invention is potential new Δ
6-fatty acid dehydrogenase.
Embodiment 3: the structure of yeast saccharomyces cerevisiae recombinant expression vector
Coding region sequence according to SEQ ID NO:1, design one pair of genes specificity amplification primer (primer 3 and primer 4):
Primer 3:MID6-1F2:5`-CG
gGATCCaTGCCTCCTAACAATAGGGCTA-3`
Primer 4:MID6-1R2:5`-AT
gCGGCCGCtCACGCATGAGGTGCTACCATC-3`
5 ‵ of these two primers hold underscore part to contain respectively
bamh I He
noti restriction enzyme site, amplification condition used and reactive component and with cDNA be template PCR reacting phase with, the sequencing result display of amplified production is consistent with the sequence of 1-1515bp shown in SEQ ID NO:1; Then 25ul PCR primer and 10ul pYES3/CT(Invitrogen company is got) carry out double digestion respectively, electrophoresis reclaims enzyme and cuts large fragment, and connect 4h with T4 ligase enzyme at 16 DEG C, connect product conversion intestinal bacteria HD5 α, by plasmid extraction and PCR screening positive clone, and carrying out order-checking qualification, plasmid construction the results are shown in Figure 2, and constructed contains Δ
6the expression vector called after pY3MID6-1 of-fatty acid dehydrogenase gene.
Embodiment 4: yeast saccharomyces cerevisiae recombinant expression vector and empty carrier transformed saccharomyces cerevisiae cell
The mono-bacterium colony of picking Wine brewing yeast strain INVSc1 is in 5ml YEPD liquid nutrient medium, and 30 DEG C of incubator overnight are cultivated, and the inoculum size by 1% is transferred in the YEPD liquid nutrient medium of 100ml, and 30 DEG C of shaking tables shake to OD600 between 1.3-1.5, 4 DEG C, 4000g centrifugal 5min collecting precipitation cell, with the aseptic ddH of 100ml precooling
2o washed cell, 4 DEG C, 4000g centrifugal 5min collecting precipitation cell, then use the aseptic ddH of 50ml precooling
2o washed cell, 4 DEG C, 4000g centrifugal 5min collecting precipitation cell, with the 1M sorbitol washes cell of 20ml precooling, 4 DEG C, 4000g centrifugal 5min collecting precipitation cell, the 1M sorbyl alcohol of the precooling of cell 0.5ml suspends, every 80ul is sub-packed in the centrifuge tube of 1.5ml precooling, get 1ug linearizing recombinant expression vector pY3MID6-1 and empty carrier pYES3/CT to join respectively in the competent cell of 80ul, go in the electric revolving cup of 0.2cm after mixing, hatch 5min on ice, proceed in electroporation (the electric shock condition: voltage 1.5kV that shocks by electricity, electric capacity 25uF, resistance 200 Ω, the electric shock time is 4-10ms), add the sorbyl alcohol of 1ml 1M precooling after electric shock immediately and blow even, 30 DEG C hatch 2h after coat SC-Trp(respectively without tryptophane) on Selective agar medium, put 30 DEG C and cultivate 3-4 days.
Embodiment 5: the abduction delivering of Yeast engineering bacteria and the gas chromatographic analysis of fatty acid methyl ester
Picking has transformed recombinant expression vector pY3MID6-1 and empty carrier pYES3/CT and the positive transformant occurred on SC-Trp Selective agar medium (tryptophane synthesis defective type substratum) flat board respectively, be inoculated in 15ml liquid SC-Trp Selective agar medium (containing 2% glucose) respectively, 30 DEG C are shaken bacterium and cultivate 24h, transfer in the SC-Trp Selective agar medium (containing the semi-lactosi of 2% and the raffinose of 1%) of 100ml, its initial OD 600 is made to be 0.4, add the xenobiotic substrates linolic acid of 0.5mmol/L, 30 DEG C are continued shaking culture 72h, 4000g collected by centrifugation thalline, with deionized water wash three times, thalline is in 50 DEG C of oven dry, grind, get the KOH-CH that 100mg dry mycelium powder adds 5ml 5%
3in OH solution, 70 DEG C of reaction 3h, are cooled to room temperature after reaction terminates, by the pH value of the hydrochloric acid conditioning solution of 6M to 2.0, add 4ml 14%BF
3-CH
3oH, 70 DEG C of reaction 1.5h, synthesizing fatty acid methyl ester, add the NaCl solution that 10ml is saturated again, concuss mixes, be transferred in separating funnel, chloroform with 8ml 1:4: hexanaphthene extracting twice, merge the extracting solution of twice, solvent nitrogen containing fatty acid methyl ester is dried up, with the normal hexane back dissolving sample of 200ul, finally with 0.45um filtering with microporous membrane removing large granular impurity.
Embodiment 6: lipid acid gas chromatographic analysis
Gas chromatographicanalyzer device is adopted to analyze the abduction delivering situation of transgenic yeast engineering bacteria, gas chromatographicanalyzer device is Shimadzu GC-7A, pillar: fused-silica capillary column, 0.32 × 30m, solid support: Dienthyeneglycol succinate plated film thing: polyimide.Carrier gas: N2, linear speed 10cm/s.Splitting ratio: 100:1, vaporizer temperature: 250 DEG C, column temperature: 180 DEG C, tail blows: 50ml/min, detector: flame ionization ditector.The methyl esterification of fatty acid sample of above-mentioned preparation is carried out GC analysis, and applied sample amount is 1ul; Analysis software: Anstar.
Stratographic analysis the results are shown in Figure the transgenic yeast of 3,4, Fig. 3 displays containing pYES3/CT empty carrier, and Fig. 4 display is containing the transgenic yeast of recombinant plasmid pY3MID6-1; Compared with Fig. 3, in Fig. 4, retention time is that the peak that 15.05min is corresponding is consistent with gamma-linolenic acid methacrylate calibration, is Mortierella isabellina M6-22 Δ
6the gamma-linolenic acid that-fatty acid enzyme catalysis linolic acid produces.
Sequence table
Sequence table
<110> Kunming University of Science and Technology
<120> Δ
6-fatty acid dehydrogenase gene and application thereof
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 1515
<212> DNA
<213> Mortierella isabellina M6-22
<400> 1
atgcctccta acaatagggc tatcgagccc actttataca aatacatcac gcagaaagag 60
ctgagtgatc gtgttaaaca aggagaggtt ctgatcatct atgacaacaa agtgtacaag 120
ctagatcgct ggatcaagtc ccatcctggt ggtgagctag ctatccgcca cgctgtagga 180
aaagatgcca cagacgagat cactgctatg catccaccac atgtatacca aaaatccatt 240
cgtccatttt atgtgggtga atatgtggaa aatatacttc acatgccaaa aactcaggca 300
ccactagcca gccacgcccc cactaccagc aataaccaaa tcgatgtaga caagtcccaa 360
tctattatca cacggttata caatgaccat atgaaagtga tccaagaaca aaaggcacgg 420
cctcaagcgg atatacaaac agtgcgtttc cactatcagc gattagagaa tgaaatccgt 480
tcacgaggtc tcatgaagtg caattactgg aagtatggca aagaatgctg tcgttatgtc 540
ttgttcattt accttgcggt ctatctgatc ctcaagggaa cgcaaacttg gcattatatg 600
ttgagtgccg tgtttatggc atgtttctgg catcagctta cattcaccgc tcatgatgct 660
ggtcacaacg gtataacagg aaaataccat atagatcacc ttataggcat attcattgcc 720
gatttccttg gtggcctttc cataggttgg tggaagaaca atcacaacgt ccatcatatt 780
gttaccaatg accctgctca cgatccggat attcagcata tgcccttttt tgccatcact 840
acccgcatct tcaacaccta ttcgagctat taccaccgcg tcatgaaatt ggatgccgcc 900
gccaaattct ttgttcgtca tcagcacaag ctttattata ttattttatc gcttggaagg 960
ttcaaccttc ataatttgag ctttgttttc ttgttcactg ctccacgtgt caaataccga 1020
tggttggaaa tctttggtat ttgtgtgttc tttacctggt attcctacct gttgtctttc 1080
ctaccgtctg cttcgatcat attcgcctac gttcttattt cttacacatt gactgtcccg 1140
ttgcacattc aaatcactct atcccatttc ggtatgtcta ctgaggatct aggacctaac 1200
gagcctttcg cagctaaaca gcttcgtacc accatggatg tcgactgccc tgaatggttt 1260
gactggttcc atggaggact tcagtaccaa gctgtacatc atttgttccc tcgcatccca 1320
agacacaatt tgcgacaatg tgtgcctttg gtcaggcagt tctgtaaaca gctcggtctc 1380
gagtaccact gttatacctt ttccaagggc aatggcgtgg tactaggtgg actcaaggct 1440
gtaggtgatc aacttcgcct tatcgacgaa gttgccaagc ataatgccga agagatggta 1500
gcacctcatg cgtga 1515
<210> 2
<211> 504
<212> PRT
<213> Mortierella isabellina M6-22
<400> 2
MET Pro Pro Asn Asn Arg Ala Ile Glu Pro Thr Leu Tyr Lys Tyr
1 10
Ile Thr Gln Lys Glu Leu Ser Asp Arg Val Lys Gln Gly Glu Val
20 30
Leu Ile Ile Tyr Asp Asn Lys Val Tyr Lys Leu Asp Arg Trp Ile
40
Lys Ser His Pro Gly Gly Glu Leu Ala Ile Arg His Ala Val Gly
50 60
Lys Asp Ala Thr Asp Glu Ile Thr Ala MET His Pro Pro His Val
70
Tyr Gln Lys Ser Ile Arg Pro Phe Tyr Val Gly Glu Tyr Val Glu
80 90
Asn Ile Leu His MET Pro Lys Thr Gln Ala Pro Leu Ala Ser His
100
Ala Pro Thr Thr Ser Asn Asn Gln Ile Asp Val Asp Lys Ser Gln
110 120
Ser Ile Ile Thr Arg Leu Tyr Asn Asp His MET Lys Val Ile Gln
130
Glu Gln Lys Ala Arg Pro Gln Ala Asp Ile Gln Thr Val Arg Phe
140 150
His Tyr Gln Arg Leu Glu Asn Glu Ile Arg Ser Arg Gly Leu MET
160
Lys Cys Asn Tyr Trp Lys Tyr Gly Lys Glu Cys Cys Arg Tyr Val
170 180
Leu Phe Ile Tyr Leu Ala Val Tyr Leu Ile Leu Lys Gly Thr Gln
190
Thr Trp His Tyr MET Leu Ser Ala Val Phe MET Ala Cys Phe Trp
200 210
His Gln Leu Thr Phe Thr Ala His Asp Ala Gly His Asn Gly Ile
220
Thr Gly Lys Tyr His Ile Asp His Leu Ile Gly Ile Phe Ile Ala
230 240
Asp Phe Leu Gly Gly Leu Ser Ile Gly Trp Trp Lys Asn Asn His
250
Asn Val His His Ile Val Thr Asn Asp Pro Ala His Asp Pro Asp
260 270
Ile Gln His MET Pro Phe Phe Ala Ile Thr Thr Arg Ile Phe Asn
280
Thr Tyr Ser Ser Tyr Tyr His Arg Val MET Lys Leu Asp Ala Ala
290 300
Ala Lys Phe Phe Val Arg His Gln His Lys Leu Tyr Tyr Ile Ile
310
Leu Ser Leu Gly Arg Phe Asn Leu His Asn Leu Ser Phe Val Phe
320 330
Leu Phe Thr Ala Pro Arg Val Lys Tyr Arg Trp Leu Glu Ile Phe
340
Gly Ile Cys Val Phe Phe Thr Trp Tyr Ser Tyr Leu Leu Ser Phe
350 360
Leu Pro Ser Ala Ser Ile Ile Phe Ala Tyr Val Leu Ile Ser Tyr
370
Thr Leu Thr Val Pro Leu His Ile Gln Ile Thr Leu Ser His Phe
380 390
Gly MET Ser Thr Glu Asp Leu Gly Pro Asn Glu Pro Phe Ala Ala
400
Lys Gln Leu Arg Thr Thr MET Asp Val Asp Cys Pro Glu Trp Phe
410 420
Asp Trp Phe His Gly Gly Leu Gln Tyr Gln Ala Val His His Leu
430
Phe Pro Arg Ile Pro Arg His Asn Leu Arg Gln Cys Val Pro Leu
440 450
Val Arg Gln Phe Cys Lys Gln Leu Gly Leu Glu Tyr His Cys Tyr
460
Thr Phe Ser Lys Gly Asn Gly Val Val Leu Gly Gly Leu Lys Ala
470 480
Val Gly Asp Gln Leu Arg Leu Ile Asp Glu Val Ala Lys His Asn
490
Ala Glu Glu MET Val Ala Pro His Ala ***
500
<210> 3
<211> 26
<212> DNA
<213> artificial sequence
<400> 3
atgcctccta acaatagggc tatcga 26
<210> 4
<211> 25
<212> DNA
<213> artificial sequence
<400> 4
tcacgcatga ggtgctacca tctct 25
<210> 5
<211> 30
<212> DNA
<213> artificial sequence
<400> 5
cgggatccat gcctcctaac aatagggcta 30
<210> 6
<211> 32
<212> DNA
<213> artificial sequence
<400> 6
atgcggccgc tcacgcatga ggtgctacca tc 32
Claims (3)
1. a Δ
6-fatty acid dehydrogenase gene, its nucleotide sequence as shown in SEQ ID NO:1, the aminoacid sequence of encoding as shown in SEQ ID NO:2.
2. a host cell, described host cell contains Mortierella isabellina Δ according to claim 1
6-fatty acid dehydrogenase gene.
3. Δ according to claim 1
6-fatty acid dehydrogenase gene is producing the application in polyunsaturated fatty acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410360120.2A CN104250650A (en) | 2014-07-28 | 2014-07-28 | Delta-6 fatty acid dehydrogenase gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410360120.2A CN104250650A (en) | 2014-07-28 | 2014-07-28 | Delta-6 fatty acid dehydrogenase gene and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104250650A true CN104250650A (en) | 2014-12-31 |
Family
ID=52185902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410360120.2A Pending CN104250650A (en) | 2014-07-28 | 2014-07-28 | Delta-6 fatty acid dehydrogenase gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104250650A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107624135A (en) * | 2015-04-28 | 2018-01-23 | 拜尔作物科学公司 | The Brassica plants of seed oil composition with modification |
CN108753810A (en) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | A kind of purposes of transcript regutation protein gene ORF2 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415754A (en) * | 2002-12-13 | 2003-05-07 | 南开大学 | Method for producing soybean containg content of high gamma-linolenic acid |
-
2014
- 2014-07-28 CN CN201410360120.2A patent/CN104250650A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415754A (en) * | 2002-12-13 | 2003-05-07 | 南开大学 | Method for producing soybean containg content of high gamma-linolenic acid |
Non-Patent Citations (3)
Title |
---|
刘莉 等: "深黄被孢霉M6-22 Δ6-脂肪酸脱氢酶基因在酿酒酵母中的表达", 《微生物学报》 * |
卜云萍 等: "深黄被孢霉Δ6-脂肪酸脱氢酶基因导入大豆", 《生物技术》 * |
王广科 等: "深黄被孢霉Δ6-脂肪酸脱氢酶基因的原核表达和转基因植株再生研究", 《成都医学院学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107624135A (en) * | 2015-04-28 | 2018-01-23 | 拜尔作物科学公司 | The Brassica plants of seed oil composition with modification |
CN108753810A (en) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | A kind of purposes of transcript regutation protein gene ORF2 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3778866B1 (en) | Recombinant yeast strain for producing nervonic acids and application thereof | |
US11345937B2 (en) | Construction of Mucor circinelloides cell factory for producing stearidonic acid and fermentation technology thereof | |
CN109097343A (en) | 11 B-hydroxylase of steroid and its encoding gene and application in Curvuluria Iunata | |
US11414650B2 (en) | Construction method of Mucor circinelloides cell factory for producing dihomo-gamma-linolenic acid and fermentation technology | |
CN101809145A (en) | Polypeptide having NADH dependent HMF reductase activity | |
CN109196091A (en) | Generate the recombinant microorganism of biosurfactant | |
CN103525842B (en) | Delta<12>-fatty acid desaturases gene and recombinant expression vector thereof | |
CN105647822A (en) | Restructured mortierella alpina with overexpression from omega-3 desaturase of phytophthora parasitica, and establishment method and application thereof | |
CN104250650A (en) | Delta-6 fatty acid dehydrogenase gene and application thereof | |
CN103525841B (en) | Delta<12>-fatty acid desaturases gene and recombinant expression vector thereof | |
CN103834672B (en) | A kind of Δ 12-fatty acid dehydrogenase gene and application thereof | |
CN111269897A (en) | DNA sequence for coding paeonia ostii delta 15 fatty acid desaturase and application thereof | |
CN104894146A (en) | Novel application of delta12-fatty acid desaturase gene | |
CN104250651A (en) | Delta-6 fatty acid dehydrogenase gene and application thereof | |
CN108753810B (en) | Application of transcriptional regulatory protein gene ORF2 | |
CN108330114B (en) | EPA-utilizing diacylglycerol acyltransferase and application thereof | |
CN1263857C (en) | Rhizopus arrhizus delta[12]-fatty acid dehydrogenase nucleic acid sequence and its uses | |
CN104212819A (en) | [Delta]<12>-fatty acid desaturase gene and application thereof | |
CN100487121C (en) | Nucleotide sequence of Pichia pastoris omega3-fatty acid dehydrogenase and application thereof | |
CN101024840B (en) | Nucleotide series of Pichia yeast delta9 fatty acid dehydro genase and use | |
Li et al. | Overexpression of an inulinase gene in an oleaginous yeast, Aureobasidium melanogenum P10, for efficient lipid production from inulin | |
AU776922B2 (en) | D-gluconolactone oxidase gene and method for producing recombinant D-gluconolactone oxidase | |
CN1286977C (en) | Nucleotide sequence of delta 6 fatty acid dehydrogenase separated from Thamnidiumelegans and application thereof | |
CN101724638A (en) | Nucleotide sequence of euglenagracilis coded delta 8 dehydrogenase and application thereof | |
CN1195060C (en) | Nucleotide series of shaogengen mould delta-6 fatty acid dehydrogenase and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141231 |
|
RJ01 | Rejection of invention patent application after publication |